Apreo Health
Latest round
- Series B
Last raised
- Aug 2025
Total raised
- $82M
Investors
- 6
About Apreo Health
, based in the US, develops advanced investigational devices focused on improving lung disease management through innovative healthcare technologies that enhance patient outcomes. Apreo Health, Inc. specializes in developing solutions for lung diseases. Founded in 2018 and headquartered in Menlo Park, US. In August 2025, Apreo Health, Inc. Apreo Health specializes in developing innovative solutions aimed at addressing lung diseases through its investigational devices. The company focuses on transformative healthcare technologies designed to enhance patient outcomes, specifically addressing conditions that impair lung function. Apreo Health’s products are tailored for clinical investigations and are utilized primarily in medical settings where lung disease management is critical. The company serves a diverse client base that includes healthcare providers, hospitals, and research institutions, ensuring that their solutions are accessible to patients in need of lung disease treatment. Apreo Health's offerings are positioned in various geographical markets, catering to both domestic and international healthcare sectors. Apreo Health's revenue model is primarily structured around direct partnerships with healthcare institutions and clinical research organizations, facilitating the distribution of their investigational devices. Transactions typically occur through direct sales to hospitals and healthcare facilities engaged in clinical investigations, where the focus is on improving patient care for lung diseases. The company’s flagship products, which are protected under trademarks like 'Making Every Breath Count,' are integral to its offerings, supporting a revenue framework that aligns with clinical needs. While specific pricing plans for individual products or services are not disclosed, the sales strategy emphasizes long-term relationships with healthcare providers to foster continued engagement and usage of Apreo Health’s innovative solutions. Apreo Health, Inc. The company aims to expand its reach into new markets and geographic regions, although specific targets and timelines have not been disclosed.
Who invested in Apreo Health
6 investors across 1 round
See all investors in Apreo Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 6, 2025
Amount
$82M
Investors
Questions about Apreo Health
Who invested in Apreo Health?
Apreo Health has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apreo Health raised?
Apreo Health has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Apreo Health last raise money?
Apreo Health's most recent round on record is a Series B, in Aug 2025.
What does Apreo Health do?
, based in the US, develops advanced investigational devices focused on improving lung disease management through innovative healthcare technologies that enhance patient outcomes.
Where is Apreo Health headquartered?
Apreo Health is headquartered in Menlo Park, US.
Which VCs invest in companies like Apreo Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Apreo Health's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Apreo Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.